MetaCap

eXoZymes Inc. (EXOZ)

NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.91-0.475 (-14.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EXOZ stock chart

Technical analysis

Key statistics

All statistics
Market cap
$27.42M
EPS (TTM)
-$1.16
52-week range
2.81 – 16.16
Day range
2.84 – 3.31
Volume / Avg
10.82K / 10.14K
Beta
—

52-week range

$2.81$16.16

EXOZ stock today

eXoZymes (EXOZ) closed at $2.91 on Nov 20, down 14.05% (-$0.475), versus the S&P 500's 3.70% decline. At this level, EXOZ sits near the bottom of its 52-week range of $2.81 to $16.16: 82.0% below the high and 3.4% above the low. EXOZ is down 73.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 81.8%.

eXoZymes has posted a net loss over the last twelve months (EPS of -$1.16), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About eXoZymes

Company profile

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing.

Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Mr. Michael Heltzen
Headquarters
Monrovia, CA
Employees
32
IPO year
2024

Financial highlights

Full financials

eXoZymes reported a net loss of $9.2 million, compared with a loss of $5.9 million a year earlier. Diluted earnings per share came in at -$1.09.

eXoZymes annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue——$70.07K
Growth———
Net income$-9.16M$-5.86M$-2.04M
EPS (diluted)$-1.09$-0.89$-0.33

Earnings

Earnings history
Last reported (Sep/2026)
Nov 13, 2026
EPS actual vs est.
$-0.24 vs —

eXoZymes peers

Health Care sector
EXOZ peer companies
CompanyPrice% ChgMarket capCompare
LONALeonaBio Inc.2.02-17.89%$26.41Mvs EXOZ
INMBINmune Bio Inc.0.827-7.50%$25.60Mvs EXOZ
PTHSPelthos Therapeutics Inc.6.38-8.73%$25.08Mvs EXOZ
SAENGenenta Science S.p.A. ADR0.5074-9.39%$24.47Mvs EXOZ
KLRSKalaris Therapeutics Inc.1.28-5.19%$30.47Mvs EXOZ
CRBUCaribou Biosciences Inc.0.2843-8.44%$30.71Mvs EXOZ
MGXMetagenomi Therapeutics Inc.0.565-7.95%$21.36Mvs EXOZ
CVMCel-Sci Corporation1.21-17.69%$21.28Mvs EXOZ

Indexes, lists and sector

eXoZymes stock FAQ

What is eXoZymes's stock price today?

EXOZ last traded at $2.91 as of Nov 20, 4:00 PM EST, down 14.05% on the day. Prices are delayed at least 15 minutes.

Who is eXoZymes's CEO?

Mr. Michael Heltzen is the chief executive officer of eXoZymes Inc., which has about 32 employees.

What is the EXOZ 52-week high?

The 52-week high for EXOZ is $16.16 and the 52-week low is $2.81. The stock is currently 82.0% below its high.

Compare EXOZ